Document Detail

Chapter 10: Calcium, Phosphate, Parathyroid Hormone, Bicarbonate and Total Cholesterol Concentrations amongst Patients Receiving Haemodialysis or Peritoneal Dialysis in England, Wales and Northern Ireland in 2009: National and Centre-Specific Analyses.
MedLine Citation:
PMID:  21894033     Owner:  NLM     Status:  In-Data-Review    
Introduction: The UK Renal Association Clinical Practice Guidelines include clinical performance measures for biochemical variables in dialysis patients [1]. The UK Renal Registry (UKRR) annually audits dialysis centre performance against these measures as part of its role in promoting continuous quality improvement. Methods: Cross sectional performance analyses were undertaken to compare dialysis centre achievement of clinical audit measures for prevalent haemodialysis (HD) and peritoneal dialysis (PD) cohorts in 2009. The biochemical variables studied were phosphate, adjusted calcium, parathyroid hormone, bicarbonate and total cholesterol. In addition longitudinal analyses were performed (2000-2009) to show changes in achievement of clinical performance measures over time. Results: Sixtyone percent of HD and 70% of PD patients had phosphate between 1.1-1.8 mmol/L. Seventy-four percent of HD and 75% of PD patients had adjusted calcium between 2.2-2.5 mmol/L. Twenty-eight percent of HD and 32% of PD patients had parathyroid hormone between 16-32 pmol/L. Seventy-two percent of HD and 83% of PD patients achieved the audit measure for bicarbonate. There was significant inter-centre variation for all variables studied. Conclusions: The UKRR consistently demonstrates significant inter-centre variation in achievement of biochemical clinical audit measures. Understanding the causes of this variation is an important part of improving the care of dialysis patients in the UK.
Clare Castledine; Dirk van Schalkwyk; Terry Feest; Retha Steenkamp; Anne Dawnay
Related Documents :
22875743 - Primary empty sella (pes): a review of 175 cases.
22147633 - Thyroid disease and compressive symptoms.
6609103 - Value of serum paba as a pancreatic function test.
Publication Detail:
Type:  Journal Article     Date:  2011-08-26
Journal Detail:
Title:  Nephron. Clinical practice     Volume:  119 Suppl 2     ISSN:  1660-2110     ISO Abbreviation:  Nephron Clin Pract     Publication Date:  2011  
Date Detail:
Created Date:  2011-09-06     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101159763     Medline TA:  Nephron Clin Pract     Country:  Switzerland    
Other Details:
Languages:  eng     Pagination:  c179-214     Citation Subset:  IM    
Copyright Information:
Copyright © 2011 S. Karger AG, Basel.
UK Renal Registry, Bristol, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  UK Renal Registry 13th Annual Report (December 2010): Chapter 9: haemoglobin, ferritin and erythropo...
Next Document:  Chapter 11: Blood Pressure Profile of Prevalent Patients receiving Renal Replacement Therapy in Engl...